Actively Recruiting
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
Led by Egymedicalpedia · Updated on 2024-07-11
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Sepsis is defined as a dysregulated host response to infection . Despite ongoing efforts, both the incidence and mortality of sepsis have demonstrated limited reductions over the past years,There are several biomarkers that have already been studied for the early diagnosis of sepsis. Some of these markers can be used in risk prediction and monitoring the outcome of sepsis . Some of these markers as procalcitonin and CD14, are costly and not feasible options for low- and middle-income countries . While other biomarkers are feasible and accessible to be evaluated as Triglyceride\\glucose index (TyG) , Relative Distributive Width of red blood corpuscles to albumin ratio (RAR), C-reactive protein,Neutrophile \\Lympocyte ratio and serum lactate levels .
CONDITIONS
Official Title
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with sepsis
- Age between 18 and 70 years
- Willingness to participate in the research
You will not qualify if you...
- Diagnosis of any hematological disease
- Refusal to participate in the research
- Age less than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assuit University Hospital
Asyut, Egypt
Actively Recruiting
Research Team
D
David Ibrahim, MSc Student
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here